| Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions D Mathew, JR Giles, AE Baxter, AR Greenplate, JE Wu, C Alanio, ... bioRxiv, 2020 | 1545* | 2020 |
| Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications D Mathew, JR Giles, AE Baxter, DA Oldridge, AR Greenplate, JE Wu, ... Science 369 (6508), eabc8511, 2020 | 1447 | 2020 |
| Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy NM Archin, AL Liberty, AD Kashuba, SK Choudhary, JD Kuruc, ... Nature 487 (7408), 482-485, 2012 | 1338 | 2012 |
| Comprehensive mapping of immune perturbations associated with severe COVID-19 L Kuri-Cervantes, MB Pampena, W Meng, AM Rosenfeld, CAG Ittner, ... Science immunology 5 (49), eabd7114, 2020 | 765 | 2020 |
| Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection EM Anderson, EC Goodwin, A Verma, CP Arevalo, MJ Bolton, ME Weirick, ... Cell 184 (7), 1858-1864. e10, 2021 | 386 | 2021 |
| Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo FR Simonetti, MD Sobolewski, E Fyne, W Shao, J Spindler, J Hattori, ... Proceedings of the National Academy of Sciences 113 (7), 1883-1888, 2016 | 377 | 2016 |
| HIV-1 Expression Within Resting CD4+ T Cells After Multiple Doses of Vorinostat NM Archin, R Bateson, MK Tripathy, AM Crooks, KH Yang, NP Dahl, ... The Journal of infectious diseases 210 (5), 728-735, 2014 | 297 | 2014 |
| Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy MF Kearney, J Spindler, W Shao, S Yu, EM Anderson, A O'Shea, C Rehm, ... PLoS pathogens 10 (3), e1004010, 2014 | 256 | 2014 |
| Assessment of maternal and neonatal cord blood SARS-CoV-2 antibodies and placental transfer ratios DD Flannery, S Gouma, MB Dhudasia, S Mukhopadhyay, MR Pfeifer, ... JAMA pediatrics 175 (6), 594-600, 2021 | 255 | 2021 |
| HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study TJ Henrich, H Hatano, O Bacon, LE Hogan, R Rutishauser, A Hill, ... PLoS medicine 14 (11), e1002417, 2017 | 232 | 2017 |
| Deep Immune Profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19 LA Vella, JR Giles, AE Baxter, DA Oldridge, C Diorio, L Kuri-Cervantes, ... Science Immunology 6 (57), 2021 | 192 | 2021 |
| SARS-CoV-2 seroprevalence among parturient women in Philadelphia DD Flannery, S Gouma, MB Dhudasia, S Mukhopadhyay, MR Pfeifer, ... Science immunology 5 (49), eabd5709, 2020 | 145 | 2020 |
| Improved single-copy assays for quantification of persistent HIV-1 viremia in patients on suppressive antiretroviral therapy AR Cillo, D Vagratian, MA Bedison, EM Anderson, MF Kearney, E Fyne, ... Journal of clinical microbiology 52 (11), 3944-3951, 2014 | 127 | 2014 |
| Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations C Diorio, KO McNerney, M Lambert, M Paessler, EM Anderson, ... Blood advances 4 (23), 6051-6063, 2020 | 123 | 2020 |
| HIV-1 in lymph nodes is maintained by cellular proliferation during antiretroviral therapy WR McManus, MJ Bale, J Spindler, A Wiegand, A Musick, SC Patro, ... The Journal of clinical investigation 129 (11), 4629-4642, 2019 | 107 | 2019 |
| UPenn COVID Processing Unit D Mathew, JR Giles, AE Baxter, DA Oldridge, AR Greenplate, JE Wu, ... Deep immune profiling of COVID-19 patients reveals distinct immunotypes with …, 2020 | 97 | 2020 |
| The role of integration and clonal expansion in HIV infection: live long and prosper EM Anderson, F Maldarelli Retrovirology 15 (1), 1-22, 2018 | 80 | 2018 |
| No evidence of ongoing HIV replication or compartmentalization in tissues during combination antiretroviral therapy: Implications for HIV eradication G Bozzi, FR Simonetti, SA Watters, EM Anderson, M Gouzoulis, ... Science Advances 5 (9), eaav2045, 2019 | 76 | 2019 |
| Immunologic perturbations in severe COVID-19/SARS-CoV-2 infection L Kuri-Cervantes, MB Pampena, W Meng, AM Rosenfeld, CAG Ittner, ... BioRxiv, 2020.05. 18.101717, 2020 | 56 | 2020 |
| Multiple sources of contamination in samples from patients reported to have XMRV infection MF Kearney, J Spindler, A Wiegand, W Shao, EM Anderson, F Maldarelli, ... PloS one 7 (2), e30889, 2012 | 48 | 2012 |
